Solutions

The same record. Six different jobs.

Underneath all six the same thing runs: the document is read, the gates evaluate what is actually on the record, and the decision is signed against the policy you wrote. What changes is which surface you work in and what you hand to whom.

503A

Control evidence at receiving and release.

Every incoming lot arrives with paperwork. It is read on arrival, gated on what is actually on the record, and written to the lot with the reason attached.

Incoming API and component evidence is split across PDFs, inboxes, spreadsheets, and binders.

  1. 01

    Capture the packet

    Supplier, product and lot number open the record, and the COA and a photo of the container label go with it. The file is hashed and read, and the photo is matched against the paperwork's product, strength and lot server side.

  2. 02

    Gate what arrives

    Seven gates evaluate what is on the record rather than what was ticked, and a panel out of scope for the preparation is not counted as a gap. One of four dispositions is written: documentation release ready, request supplier correction, quarantine pending evidence, or hold for human review.

  3. 03

    Keep the record connected

    The lot re-derives from its whole document set, and when your policy has auto-decide on, ClearGate re-runs on the lot and stores a signed decision. A recall published months later lands on that same lot.

Sample workspace · not a live account

Order Channel

Orders

8 of 8 shown
Sample orders and their ClearGate decisions. Every row is fictional.
OrderSupplierProductLotClearGateReceived
ORD-DEMO-1084Aurora Pharma SupplySemaglutide (base) APILOT-7741-AClearGate decision: Allow

Six-document packet complete; issuing lab confirmed the COA

Jul 22, 2026
ORD-DEMO-1085Keystone Peptide LabsTirzepatide APILOT-KP-2407ClearGate decision: Review

Sterility and endotoxin evidence not supplied

Jul 22, 2026
ORD-DEMO-1086BlueRiver API CoBPC-157LOT-BR-0816ClearGate decision: Hold

COA lot and shipment label do not match; route unreachable

Jul 21, 2026
ORD-DEMO-1087Meridian Compounding SourceLidocaine HClLOT-MC-1129ClearGate decision: Allow

Six of six qualification elements on file; packet complete

Jul 21, 2026
ORD-DEMO-1088Aurora Pharma SupplyAscorbic AcidLOT-ASP-1180ClearGate decision: Allow

Packet complete; no indexed reuse signal

Jul 20, 2026
ORD-DEMO-1089Meridian Compounding SourceGlutathioneLOT-MC-1131ClearGate decision: Allow

Packet complete; residual solvents within the printed specification

Jul 17, 2026
ORD-DEMO-1090Keystone Peptide LabsSermorelinLOT-KP-2411ClearGate decision: Review

Undisclosed salt form on the COA; net peptide content unstated

Jul 16, 2026
ORD-DEMO-1091Aurora Pharma SupplyMethylcobalaminLOT-7748-BClearGate decision: Allow

Packet complete; certificate of conformance on file

Jul 15, 2026

A faster, more consistent evidence record, without replacing the receiving decision.

Boundary

A COA check or Passport records whether the documents are complete and consistent. It is not a safety, quality, efficacy, legality, or FDA-approval claim.

Outsourcing facilities

Publish a record customers can inspect.

Give your customers a dated, independent record of every lot you ship.

A self-published portal cannot provide an independent record of what was checked and what stays outside scope.

  1. 01

    Create the scoped profile

    Represented identity and documentation elements are published with the label that says who established each one: Veritura evaluated, operator attested, or source-confirmed. Every dated document carries its own current, due, or overdue state.

  2. 02

    Release eligible Passports

    A passport mints from a cleared lot or not at all. Every refusal names what is unmet: the lot is not cleared, a ClearGate hold stands, a recall signal stands, or your policy requires a human-reviewed lot.

  3. 03

    Keep changes visible

    A later enforcement match stamps a post-release signal on every passport minted from that lot, without rewriting the decision that released it. Corrections, credential state and source refreshes stay dated and inspectable.

Sample workspace · not a live account

Evidence Passport

Semaglutide (base) API

V-SBX-00013

Documentation completeness

Documentation reads complete

Stated in words, with no numeric score. A paperwork-completeness read, never a product-quality or safety determination.

Certificate of analysis

Source-confirmed

The issuing laboratory confirmed issuance through the recorded verification route.

Order
PO-DEMO-0413
Lot
LOT-7741-A
Supplier
Aurora Pharma Supply
Quantity
250 g
Received
July 22, 2026
Released
July 23, 2026
Passport issued
July 23, 2026
Methodology
v1.0 · April 30, 2026

Documents on file

6

  • Certificate of analysis

    COA-7741-A.pdf · Issuing laboratory confirmed issuance through the recorded route

    Source-confirmed
  • Certificate of conformance

    CoC-7741.pdf · Required identity, lot, and date fields present

    Veritura evaluated
  • Safety data sheet

    SDS-SEMA-04.pdf · Current revision on file

    Veritura evaluated
  • GMP certificate

    GMP-AUR-2026.pdf · Supplied by the operator

    Operator attested
  • Receiving inspection

    Recorded in workspace · Container and label checked at receipt

    Operator attested
  • Shipment label

    LBL-7741-A.jpg · Lot identifier matches the certificate of analysis

    Veritura evaluated

What this record does not establish

  • Documentation diligence only. No product was tested and no supplier was approved.
  • Absence of a public-source match is not proof of absence.
  • Produced under methodology v1.0, April 30, 2026.

Customer-safe documentation proof, without product approval or certification.

Boundary

Veritura verifies the completeness and consistency of documentation and sourcing, not product quality, safety, efficacy, legality, or FDA approval. A "Verified by Veritura" profile or check means the submitted paperwork was read for documentation completeness, consistency, and evidence status; it is not a certification, an approval, or a representation that any product is safe.

Clinics

Screen the paperwork before you order.

Screen it before you order. Keep the record after it arrives.

A clinic relies on documentation created across suppliers, laboratories, and dispensing partners.

  1. 01

    Screen the paperwork

    ClearGate reads the supplier's qualification file and the lot against your policy before the purchase. The answer comes back Allow, Review, or Hold, and every reason names the rule that fired.

  2. 02

    Share the released record

    The record you hand someone prints the substance, the lot, the order reference, what the certificate stated, the lab and the date. Documentation completeness is stated in plain words, never as a score.

  3. 03

    Review later notices

    A matched enforcement record flags the lot in every account that logged it and appends a post-release signal to the passports minted from it. The signed decision you already made stays exactly as it was.

Sample workspace · not a live account

Inspection readiness

Reports

5 generated this month
Sample generated reports. Every record referenced is fictional.
ReportTypeEvidence originGeneratedLengthDownload
Board-Ready inspection binderRPT-DEMO-0142Inspection readinessVeritura evaluatedJul 26, 202635 pages
Supplier qualification file · Aurora Pharma SupplyRPT-DEMO-0141QualificationOperator attestedJul 24, 202612 pages
Sourcing Decision Receipt · SRC-DEMO-31RPT-DEMO-0140SourcingVeritura evaluatedJul 23, 20264 pages
Lot evidence packet · LOT-7741-ARPT-DEMO-0139Lot evidenceSource-confirmedJul 23, 202618 pages
Monitoring summary · captured public sourcesRPT-DEMO-0138MonitoringVeritura evaluatedJul 20, 20266 pages

The evidence, the questions, and the decision receipt stay connected to the order.

Boundary

A COA check or Passport records whether the documents are complete and consistent. It is not a safety, quality, efficacy, legality, or FDA-approval claim.

Med spas

Let a patient see the paperwork behind their lot.

A patient scans the vial and reads the record for their exact lot.

Patients see strong product claims but cannot inspect the documentation record or its limits.

  1. 01

    Scan the released seal

    The QR on the vial carries a serial in the shape VS-XXXX-XXXX, printed from a 30-symbol alphabet with every ambiguous character removed. Scanning it, or typing it, opens the record for that exact lot.

  2. 02

    Read the evidence record

    The page shows the substance, the lot, what the certificate stated, the lab and the date, and states documentation completeness in plain words with no score. No report IDs, no file names, no hashes: the certificate stays with the pharmacy.

  3. 03

    Know who to ask

    Saving a vial stores an email, the serial and the notice history, so one button can reach that person if the lot's documentation record changes. Care questions stay with the dispensing clinician or pharmacy, and record corrections route to Veritura.

Sample data · not a live account

Evidence Passportveritura

Semaglutide (base) API

LOT-7741-A

Documentation

Reads complete

Origin

Source-confirmed
Supplier
Aurora Pharma Supply
Order
PO-DEMO-0413
Released
July 23, 2026

Documents

6

  • Certificate of analysis

    Source-confirmed

  • Certificate of conformance

    Veritura evaluated

  • Safety data sheet

    Veritura evaluated

Evidence Passport · Local sample data. Not a live account. Every supplier, lot, order, and document shown here is fictional.

Plain-language provenance instead of a numeric score a patient could mistake for a safety rating.

Boundary

A COA check or Passport records whether the documents are complete and consistent. It is not a safety, quality, efficacy, legality, or FDA-approval claim.

Platforms

Carry the evidence across every partner.

Proof on every order, by API, across every partner you route to.

A platform routes orders across multiple partners while the documentation record stays fragmented.

  1. 01

    Evaluate the order

    POST the document to /v1/check with a Bearer key and the order is read against your configured policy. The answer carries its reasons and the policy version, and over the per-key concurrency limit you get a 429 with Retry-After rather than a silent queue.

  2. 02

    Release eligible proof

    A passport releases from a cleared lot or not at all. An order that arrived before its lot cleared parks at source_review, so nothing is lost and nothing is published early.

  3. 03

    Map a later signal

    passport.issued, lot.recall_hit and supplier.alert are the three subscribable events, each signed with an HMAC over the body. A matched notice reaches every linked lot, order and passport without rewriting the earlier decision.

Sample workspace · not a live account

Supplier intelligence

Documentation exposure

18 of 24 qualification elements on file

Exposure index

81/ 100

Plain mean of the five factor values below. It measures the documentation on file, not the medicine, the supplier, or the outcome.

  • Identity and lot alignment

    Submitted documents whose identity, lot, and date fields agree with the shipment record

    92 / 100
    Evidence posture: Clear
  • Testing scope completeness

    Lots whose packet carries every test the workspace policy requires

    74 / 100
    Evidence posture: Review
  • Source-route reachability

    Certificates whose published verification route answered when it was called

    83 / 100
    Evidence posture: Clear
  • Public-source coverage

    Suppliers with a dated openFDA enforcement and recall capture on file

    96 / 100
    Evidence posture: Clear
  • Qualification currency

    Qualification elements on file and within their review date

    61 / 100
    Evidence posture: Review

Qualification coverage

On fileDue for reviewNot supplied
Manufacturer identity
Accreditation
FDA registration status
Quality agreement
Documentation specifications
Ongoing review
Aurora Pharma Supply
Aurora Pharma Supply, Manufacturer identity: On file
Aurora Pharma Supply, Accreditation: On file
Aurora Pharma Supply, FDA registration status: On file
Aurora Pharma Supply, Quality agreement: On file
Aurora Pharma Supply, Documentation specifications: On file
Aurora Pharma Supply, Ongoing review: Due for review
Meridian Compounding Source
Meridian Compounding Source, Manufacturer identity: On file
Meridian Compounding Source, Accreditation: On file
Meridian Compounding Source, FDA registration status: On file
Meridian Compounding Source, Quality agreement: On file
Meridian Compounding Source, Documentation specifications: On file
Meridian Compounding Source, Ongoing review: On file
Keystone Peptide Labs
Keystone Peptide Labs, Manufacturer identity: On file
Keystone Peptide Labs, Accreditation: On file
Keystone Peptide Labs, FDA registration status: On file
Keystone Peptide Labs, Quality agreement: On file
Keystone Peptide Labs, Documentation specifications: Due for review
Keystone Peptide Labs, Ongoing review: Due for review
BlueRiver API Co
BlueRiver API Co, Manufacturer identity: On file
BlueRiver API Co, Accreditation: Due for review
BlueRiver API Co, FDA registration status: Not supplied
BlueRiver API Co, Quality agreement: On file
BlueRiver API Co, Documentation specifications: On file
BlueRiver API Co, Ongoing review: Not supplied

This panel measures the documentation on file. It is not a safety, quality, or product-performance measure, not a supplier ranking, and not an approval. An element shown as not supplied is a gap in the paperwork, not a finding about the medicine.

ClearGate, Passport, and notice events fit the order workflow you already run.

Boundary

A COA check or Passport records whether the documents are complete and consistent. It is not a safety, quality, efficacy, legality, or FDA-approval claim.

Supply side

Carry a credential any buyer can check.

Get your documentation read by a party that does not sell the product.

Every supplier says their paperwork is complete. Buyers have no independent way to confirm it.

  1. 01

    Get the profile

    Your documents go through the same four lanes a buyer's do: the issuing lab, the standard, the file's own internals, and every other document on record. Each element is published with the label that says who established it.

  2. 02

    Hand over the verify link

    Use the credential and its link on your site, in a diligence request, or with existing customers. A buyer opens it and reads what was checked, what is still could-not-verify, and the date each element was captured.

  3. 03

    Stay current

    Optional monitoring runs two sweeps on a cycle: FDA enforcement queried by firm name, and a broader net that scans recent enforcement records for lot numbers already on record. Only a lot-level match, or a confirmed or strong firm-name match, sends an email; a weak name-only match surfaces for review instead.

Sample workspace · not a live account

Supplier qualification

Suppliers

4 active · 6-element file each
Sample supplier qualification files. Every supplier named is fictional.
SupplierStatusQualificationDocumentation scoreLast checkFile posture
Aurora Pharma SupplyDistributorActive5 of 6 elements92 / 100Jul 24, 2026Evidence posture: Clear

Ongoing review due Jul 30

Meridian Compounding SourceDistributorActive6 of 6 elements96 / 100Jul 23, 2026Evidence posture: Clear

No open request

Keystone Peptide LabsLaboratoryActive4 of 6 elements74 / 100Jul 22, 2026Evidence posture: Review

Sterility scope gap

BlueRiver API CoManufacturerUnder review3 of 6 elements58 / 100Jul 21, 2026Evidence posture: Hold

Corrected source route requested

The score grades the documentation evidence on file only. It is not an approval, a ranking, a certification, or a statement about any product.

Independent and portable. It works with any buyer, with or without a partner network.

Boundary

A "Verified by Veritura" profile or badge means an automated documentation profile checked submitted paperwork for completeness, consistency, field identity, forensic signals, FDA-registration evidence status, and an active public verify link, by a party that does not sell the product. It is not a certification, an approval, a human review, or a claim that any product is safe, effective, legal, or FDA-approved, and it may not be presented as one.

Boundary

Veritura does not test medicine, approve suppliers, recommend purchases, or make medical, legal, product-safety, or FDA-approval determinations. There is no paid or subjective placement: suppliers cannot pay for a better result or a better position, no listing fee, no subscription, and no pay-to-rank. Where results are ordered rather than filtered, the order is set by a published documentation-coverage grade, and that grade is never a recommendation, a preference, or a statement about any product.

Let's make your supplier evidence defensible.

Send a note, whether it is one document or a whole supplier base. We run your own paperwork through the check and show you what is present, what is missing, and where the trail is exposed.